These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
766 related items for PubMed ID: 26419507
1. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer. Ye WL, Zhao YP, Li HQ, Na R, Li F, Mei QB, Zhao MG, Zhou SY. Sci Rep; 2015 Sep 30; 5():14614. PubMed ID: 26419507 [Abstract] [Full Text] [Related]
2. Actively targeted delivery of doxorubicin to bone metastases by a pH-sensitive conjugation. Ye WL, Zhao YP, Na R, Li F, Mei QB, Zhao MG, Zhou SY. J Pharm Sci; 2015 Jul 30; 104(7):2293-303. PubMed ID: 25980534 [Abstract] [Full Text] [Related]
3. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin. Cong Y, Quan C, Liu M, Liu J, Huang G, Tong G, Yin Y, Zhang C, Jiang Q. J Biomater Sci Polym Ed; 2015 Jul 30; 26(11):629-43. PubMed ID: 25994241 [Abstract] [Full Text] [Related]
4. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases. Miller K, Clementi C, Polyak D, Eldar-Boock A, Benayoun L, Barshack I, Shaked Y, Pasut G, Satchi-Fainaro R. Biomaterials; 2013 May 30; 34(15):3795-806. PubMed ID: 23434349 [Abstract] [Full Text] [Related]
5. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake. Xu Y, Lu Y, Wang L, Lu W, Huang J, Muir B, Yu J. Colloids Surf B Biointerfaces; 2016 May 01; 141():318-326. PubMed ID: 26874117 [Abstract] [Full Text] [Related]
6. Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity. Song YF, Liu DZ, Cheng Y, Liu M, Ye WL, Zhang BL, Liu XY, Zhou SY. Sci Rep; 2015 Nov 04; 5():16125. PubMed ID: 26530454 [Abstract] [Full Text] [Related]
7. Preparation of core cross-linked PCL-PEG-PCL micelles for doxorubicin delivery in vitro. Zhang J, Men K, Gu Y, Wang X, Gou M, Guo G, Luo F, Qian Z. J Nanosci Nanotechnol; 2011 Jun 04; 11(6):5054-61. PubMed ID: 21770143 [Abstract] [Full Text] [Related]
8. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice. Gao ZG, Lee DH, Kim DI, Bae YH. J Drug Target; 2005 Aug 04; 13(7):391-7. PubMed ID: 16308207 [Abstract] [Full Text] [Related]
9. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Min KH, Lee HJ, Kim K, Kwon IC, Jeong SY, Lee SC. Biomaterials; 2012 Aug 04; 33(23):5788-97. PubMed ID: 22591612 [Abstract] [Full Text] [Related]
10. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery. Chen T, Xiao Y, Lu W, Liu S, Gan L, Yu J, Huang J. Colloids Surf B Biointerfaces; 2018 Jan 01; 161():606-613. PubMed ID: 29156337 [Abstract] [Full Text] [Related]
11. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release. Zhang Y, Xiao Y, Huang Y, He Y, Xu Y, Lu W, Yu J. Colloids Surf B Biointerfaces; 2020 Apr 01; 188():110772. PubMed ID: 31999965 [Abstract] [Full Text] [Related]
12. Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy. Xi Y, Jiang T, Yu Y, Yu J, Xue M, Xu N, Wen J, Wang W, He H, Shen Y, Chen D, Ye X, Webster TJ. Int J Nanomedicine; 2019 Apr 01; 14():6425-6437. PubMed ID: 31496695 [Abstract] [Full Text] [Related]
13. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release. Chen W, Meng F, Cheng R, Deng C, Feijen J, Zhong Z. J Control Release; 2015 Jul 28; 210():125-33. PubMed ID: 25987525 [Abstract] [Full Text] [Related]
14. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma. Xiao K, Luo J, Li Y, Lee JS, Fung G, Lam KS. J Control Release; 2011 Oct 30; 155(2):272-81. PubMed ID: 21787818 [Abstract] [Full Text] [Related]
15. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release. Wei R, Cheng L, Zheng M, Cheng R, Meng F, Deng C, Zhong Z. Biomacromolecules; 2012 Aug 13; 13(8):2429-38. PubMed ID: 22746534 [Abstract] [Full Text] [Related]
16. Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer. Gao X, Wang B, Wei X, Rao W, Ai F, Zhao F, Men K, Yang B, Liu X, Huang M, Gou M, Qian Z, Huang N, Wei Y. Int J Nanomedicine; 2013 Aug 13; 8():971-82. PubMed ID: 23493403 [Abstract] [Full Text] [Related]
18. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer. He Y, Huang Y, Huang Z, Jiang Y, Sun X, Shen Y, Chu W, Zhao C. J Control Release; 2017 Oct 28; 264():76-88. PubMed ID: 28842315 [Abstract] [Full Text] [Related]